Dr. Tariot is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
901 E Willetta St
3rd Floor
Phoenix, AZ 85006Phone+1 602-239-6967
Education & Training
- National Institutes of Health Clinical CenterResidency, Psychiatry, 1983 - 1986
- University of Wisconsin Hospitals and ClinicsResidency, Psychiatry, 1981 - 1983
- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1978 - 1981
- University of Rochester School of Medicine and DentistryClass of 1978
Certifications & Licensure
- AZ State Medical License 2005 - 2027
- NY State Medical License 1986 - 2023
- WI State Medical License 1979 - 1987
- American Board of Internal Medicine Internal Medicine
- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- Top Doctors:Arizona State Castle Connolly, 2013
- Super Doctor SuperDoctors.com
Clinical Trials
- CATIE-Alzheimer's Disease Trial Start of enrollment: 2001 Mar 01
- Valproate in Dementia (VALID) Start of enrollment: 2003 Oct 01
- Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects Start of enrollment: 2013 Dec 01
Publications & Presentations
PubMed
- Impact of APOE ε4 and ε2 on plasma neurofilament light chain and cognition in autosomal dominant Alzheimer's disease.Stephanie Langella, Kyra Bonta, Yinghua Chen, Yi Su, Daniel Vasquez
Alzheimer's Research & Therapy. 2024-10-01 - 5 citationsEffects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE ε4 homozygotes.Marie-Emmanuelle Riviere, Jessica B Langbaum, R Scott Turner, Juha O Rinne, Yihan Sui
Alzheimer's & Dementia. 2024-03-01 - 2 citationsRelationships of change in Clinical Dementia Rating (CDR) on patient outcomes and probability of progression: observational analysis.Pierre N Tariot, Mercè Boada, Krista L Lanctôt, Julie Hahn-Pedersen, Firas Dabbous
Alzheimer's Research & Therapy. 2024-02-15
Authored Content
- Silver Synapses: Themes from an International Conference on Alzheimer’s DiseaseOctober 2018
Press Mentions
- A New Drug Could Slow Alzheimer’s Disease, Data ShowNovember 30th, 2022
- Alzheimer's Researchers Delve into Data from Failed Crenezumab TrialAugust 5th, 2022
- Landmark Alzheimer's Prevention Trial Unable to Show Significantly Slower Cognitive Decline in Inherited Form of DiseaseJune 16th, 2022
- Join now to see all
Grant Support
- Alzheimer's Prevention InitiativeNational Institute on Aging2012–Present
- Trial Of Valproate To Attenuate The Progression Of ADNational Institute On Aging2001–2002
- Divalproex Sodium Therapy For Agitation And Dementia In The Nursing HomeNational Institute On Aging1996–2001
- Core--ClinicalNational Institute On Aging1995–2000
- Geriatric Mental Health Academic AwardNational Institute Of Mental Health1988–1992
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: